news
Moscow Region Government and Petrovax Pharm sign cooperation agreement
The partnership aims to foster entrepreneurship and innovative technologies in the Moscow Region and to implement Russia’s first full-cycle manufacturing project for a vaccine against meningococcal infection, including in-house synthesis of the drug substance
U.S. Geneticist Who Developed Enzyme Replacement Therapy for Fabry Disease Endorses the Russian Biosimilar Fabagal®
Experts predict more novel biotech drug launches in Russia’s market
Russian patients get access to first immuno-oncology drug to treat nasopharyngeal cancer
Board of Experts: iron deficiency anemia is a hidden danger for women and the elderly
New stage in treating osteoporosis and osteoarthritis — state-of-the art therapeutic approach
Petrovax Pharm secures award at Man and Medicine congress
The first-ever biosimilar of original medicine for osteoporosis treatment has been approved in the Russian Federation
Petrovax Pharm gets the best project of the year award for its market launch of Areima®
